Cognitive · Cognitive peptide (research)
Cerebroprotein Hydrolysate
- Drug class
- Cognitive peptide (research)
- Status
- Compounded (503A)
- Also known as
- cerebrolysin, brain peptide hydrolysate, cerebroprotein hydrolysate
- Reviewed
- 2026-06-01 · Dr. Ana Lisa Carr, MD
What Cerebroprotein Hydrolysate is studied for
- Neurotrophic support (research)
- Cognitive recovery research (research)
- Stroke rehab research (research)
Mechanism of action
Cerebroprotein Hydrolysate is being studied in the cognitive category. Porcine brain peptide hydrolysate studied for neurotrophic and cognitive support. Mechanism of action varies by study model; refer to the kindr clinical library for a deeper writeup.
Frequently asked questions
What is Cerebroprotein Hydrolysate?
Cerebroprotein Hydrolysate is a cognitive peptide. Porcine brain peptide hydrolysate studied for neurotrophic and cognitive support.
What is Cerebroprotein Hydrolysate studied for?
Published research has examined Cerebroprotein Hydrolysate for neurotrophic support, cognitive recovery research, stroke rehab research. Human clinical evidence varies by indication.
Is Cerebroprotein Hydrolysate FDA-approved?
No. Cerebroprotein Hydrolysate is not FDA-approved for the indications listed. It is available compounded by 503A pharmacies under clinician supervision, or for international research use only on this catalog.
How is Cerebroprotein Hydrolysate used in research?
Protocols vary by study. Cerebroprotein Hydrolysate is typically administered subcutaneously in research settings. No validated human therapeutic dose exists outside FDA-approved indications.
What are the known risks?
Long-term human safety data for Cerebroprotein Hydrolysate is limited. Theoretical risks vary by mechanism. Any human use should be supervised by a licensed clinician.